Literature DB >> 16137961

Manual small incision cataract surgery in eyes with white cataracts.

Rengaraj Venkatesh1, Manoranjan Das, Sadasivam Prashanth, Radhakrishnan Muralikrishnan.   

Abstract

PURPOSE: To assess the safety and efficacy of Manual Small Incision Cataract Surgery (MSICS) in cases of white cataract with the use of trypan blue as an adjunct for performing continuous curvilinear capsulorthexis (CCC).
MATERIALS AND METHODS: Prospective observational study on 100 consecutive eyes of 100 patients with white cataract who had undergone MSICS with trypan blue assisted CCC. The nucleus was prolapsed into anterior chamber by using a sinskey hook and extracted out of the eye using irrigating vectis. Intraoperative and postoperative findings (according to OCTET classification) as well as postoperative visual outcomes were used as main measures to report the safety and efficacy of the surgery.
RESULTS: Of the 100 eyes, 16 had intumescent, 67 had mature and 17 had hypermature cataract. Intraoperatively CCC was incomplete in 4 eyes (4%) and had to be converted to canopener capsulotomy. None of the eyes had posterior capsular rupture or zonular dialysis and no eyes were converted to conventional Extra Capsular Cataract Extraction (ECCE). Postoperatively, 6 eyes (6%) developed corneal oedema with >10 Descemets folds and 7 eyes (7%) had corneal oedema with
CONCLUSION: In developing countries like India where phacoemulsification may not be affordable to a majority of those requiring cataract surgery, MSICS proves to be a safe and efficacious alternative for white cataracts especially with the adjunctive use of trypan blue dye.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137961     DOI: 10.4103/0301-4738.16675

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  19 in total

1.  Manual small incision cataract surgery in the United Kingdom.

Authors:  Colin S H Tan; Rengaraj Venkatesh
Journal:  Int Ophthalmol       Date:  2010-10-23       Impact factor: 2.031

2.  Extra Large Temporal Tunnel Cataract Extraction [ETCE].

Authors:  Chidanand Kulkarni; Vivekanand U
Journal:  J Clin Diagn Res       Date:  2014-09-20

3.  Nucleus management with irrigating vectis.

Authors:  Aravind Srinivasan
Journal:  Indian J Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.848

4.  Visual prognosis, intraocular pressure control and complications in phacomorphic glaucoma following manual small incision cataract surgery.

Authors:  R Ramakrishanan; Devendra Maheshwari; Mohideen Abdul Kader; Rita Singh; Neelam Pawar; M Jayahar Bharathi
Journal:  Indian J Ophthalmol       Date:  2010 Jul-Aug       Impact factor: 1.848

5.  Manual small incision cataract surgery in a United Kingdom university teaching hospital setting.

Authors:  Ghee Soon Ang; Samantha Wheelan; Frank D Green
Journal:  Int Ophthalmol       Date:  2009-01-08       Impact factor: 2.031

6.  Mini-rhexis for white intumescent cataracts.

Authors:  Newton Kara-Junior; Marcony Rodrigues de Santhiago; Andrea Kawakami; Pedro Carricondo; Wilson Takashi Hida
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 7.  Small incision cataract surgery: Complications and mini-review.

Authors:  Parikshit M Gogate
Journal:  Indian J Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 1.848

8.  Lens capsule-related problems in patients undergoing phacoemulsification surgery.

Authors:  Lokman Aslan; Adnan Aksoy; Murat Aslankurt; Murat Ozdemir
Journal:  Clin Ophthalmol       Date:  2013-03-09

9.  Primary posterior capsular opacification in Indian rural population undergoing cataract surgery for hypermature senile cataract.

Authors:  Rajesh Subhash Joshi
Journal:  Clin Ophthalmol       Date:  2013-08-08

10.  Cost-effectiveness analysis should continually assess competing health care options especially in high volume environments like cataract surgery.

Authors:  Ashiya Khan; Abadan Khan Amitava; Syed Ali Raza Rizvi; Ziya Siddiqui; Namita Kumari; Shivani Grover
Journal:  Indian J Ophthalmol       Date:  2015-06       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.